Cover Image
市場調查報告書

Zeria Pharmaceutical Co Ltd:產品平台分析

Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224668
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
Zeria Pharmaceutical Co Ltd:產品平台分析 Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年09月30日 內容資訊: 英文 38 Pages
簡介

Zeria Pharmaceutical Co Ltd 是從事醫藥品,動物用醫藥品,非製藥產品,農藥,工業用化學物質,試劑的製造及進出口的製藥公司。該公司同時也在製造及銷售化妝品,酒精飲料,食品添加物,保健食品,家畜的飼料,衛生用品,醫療設備,健康器具,衛生設施,衛生器具,碳酸飲料,美容器具,測量器,分析設備等。

本報告提供Zeria Pharmaceutical Co Ltd的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Zeria Pharmaceutical Co Ltd的基本資料

Zeria Pharmaceutical Co Ltd概要

  • 主要資訊
  • 企業資料

Zeria Pharmaceutical Co Ltd :R&D概要

  • 主要的治療範圍

Zeria Pharmaceutical Co Ltd :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Zeria Pharmaceutical Co Ltd :開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式

Zeria Pharmaceutical Co Ltd :藥物簡介

  • acotiamide hydrochloride
  • mycobacterium tuberculosis ext
  • polaprezinc
  • ZOSA-0
  • ZOY-60
  • Z-360
  • E-3710
  • ferric carboxymaltose

Zeria Pharmaceutical Co Ltd :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Zeria Pharmaceutical Co Ltd :最近的開發平台趨勢

Zeria Pharmaceutical Co Ltd :暫停中的計劃

Zeria Pharmaceutical Co Ltd :開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • acotiamide hydrochloride

Zeria Pharmaceutical Co Ltd :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07601CDB

Summary

Global Markets Direct's, 'Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Zeria Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Zeria Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Zeria Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Zeria Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Zeria Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Zeria Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Zeria Pharmaceutical Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Zeria Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Zeria Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zeria Pharmaceutical Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Zeria Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Zeria Pharmaceutical Co., Ltd. Snapshot
    • Zeria Pharmaceutical Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Zeria Pharmaceutical Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Zeria Pharmaceutical Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Zeria Pharmaceutical Co., Ltd. - Pipeline Products Glance
    • Zeria Pharmaceutical Co., Ltd. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Zeria Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Zeria Pharmaceutical Co., Ltd. - Drug Profiles
    • acotiamide hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • polaprezinc
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Z-100
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ZOSA-0
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • E-3710
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Z-360
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ferric carboxymaltose
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Zeria Pharmaceutical Co., Ltd. - Pipeline Analysis
    • Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Target
    • Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
    • Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
    • Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
  • Zeria Pharmaceutical Co., Ltd. - Recent Pipeline Updates
  • Zeria Pharmaceutical Co., Ltd. - Dormant Projects
  • Zeria Pharmaceutical Co., Ltd. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • acotiamide hydrochloride
  • Zeria Pharmaceutical Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Zeria Pharmaceutical Co., Ltd., Key Information
  • Zeria Pharmaceutical Co., Ltd., Key Facts
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Indication, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015
  • Zeria Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Zeria Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015
  • Zeria Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
  • Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products in Pipeline, 2015
  • Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Zeria Pharmaceutical Co., Ltd. - Phase III, 2015
  • Zeria Pharmaceutical Co., Ltd. - Phase II, 2015
  • Zeria Pharmaceutical Co., Ltd. - Phase I, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Target, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Zeria Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2015
  • Zeria Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2015
  • Zeria Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2015
  • Zeria Pharmaceutical Co., Ltd., Other Locations
  • Zeria Pharmaceutical Co., Ltd., Subsidiaries

List of Figures

  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015
  • Zeria Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Zeria Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015
  • Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products in Pipeline, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top